1. Poznyak AV, Sadykhov NK, Kartuesov AG, Borisov EE, Melnichenko AA, Grechko AV, Et al . Hypertension as a risk factor for atherosclerosis: Cardiovascular risk assessment. Front Cardiovasc Med. 2022; 9: 959285. DOI: 10.3389/fcvm.2022.959285 [
DOI:10.3389/fcvm.2022.959285] [
PMID] [
]
2. S Sarrafzadegan N, Mohammadifard N. Cardiovascular disease in Iran in the last 40 years: prevalence, mortality, morbidity, challenges and strategies for cardiovascular prevention. Arch Iran Med. 2019; 22(4): 204-210 PMID: 31126179
3. Kazemy T, Sharifzadeh G. The proportion of CVD from total death in Birjand 2002-2003. Journal of Inflammatory Diseases.2005;8(4):73-76.[Persian].URL: http://journal.qums.ac.ir/article-1-173-en.html
4. Kazemi T, Sharifzadeh GH. Investigating the causes of death in the population covered by Birjand University of Medical Sciences in 2002. J Birjand Univ Med Sci. 2003; 10(2): 17-22. [Persian] URL: https://sid.ir/paper/95481/fa
5. Pirayesh Z, Riahi SM, Bidokhti A, Kazemi T. Evaluation of the effect of the COVID-19 pandemic on the all-cause, cause-specific mortality, YLL, and life expectancy in the first 2 years in an Iranian population-an ecological study. Front Public Health. 2023; 11: 1259202. DOI: 10.3389/fpubh.2023.1259202 [
DOI:10.3389/fpubh.2023.1259202] [
PMID] [
]
6. Global Cardiovascular Risk Consortium. Global effect of modifiable risk factors on cardiovascular disease and mortality. N Engl J Med. 2023; 389(14): 1273-85. DOI: 10.1056/NEJMoa2206916 [
DOI:10.1056/NEJMoa2206916] [
PMID] [
]
7. Lloyd-Jones DM, Allen NB, Anderson CA, Black T, Brewer LC, Foraker RE, et al. Life's essential 8: updating and enhancing the American Heart Association's construct of cardiovascular health: a presidential advisory from the American Heart Association. Circulation. 2022; 146(5): e18-43. DOI: 10.1161/CIR.0000000000001078 [
DOI:10.1161/CIR.0000000000001078]